Investigators reported findings from the first randomized trial to evaluate the use of metastasis-directed therapy with hormone therapy in patients with oligometastatic prostate cancer.
Currently available early detection methods for PDAC vary in diagnostic accuracy, which has researchers exploring alternatives for helping patients at high risk.
HIPAA protects patients from unauthorized disclosure of personal information by covered entities such as medical practices and hospitals, but out from under the HIPAA umbrella, patients are mostly on their own, according to the authors of a recent report.
Surrogate decision makers for a patient are obligated to make health care decisions based on what the patient would have wanted if it is known.
Sameed Khatana MD, and Barrak Alahmad, MD, discuss the impact of climate change on patients’ risk for cardiovascular disease.
Rheumatologists, Joshua Baker, MD, Brian Andonian, MD, and Ira Khanna, MD, discuss the occurrence and management of muscle weakness and loss among patients with rheumatoid arthritis.
Novel treatments for metastatic prostate cancer have prolonged lives, but the survival benefits remain modest.
Endocrinology Advisor just got a makeover! Along with the fresh look and feel of the site, we’ve also refined our approach for delivering the content you need to serve your patients. In the reimagined Endocrinology Advisor — part of Haymarket Medical Network’s suite of clinical resources — we’ve expanded our clinical content to bring you…
Changes to abortion laws in the US could have unintended consequences for cancer patients and others seeking fertility preservation.